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response. Short-circuit current (Isc ϭ chloride secretion) was recorded in mucosa-SMP in flux chambers. A distension reflex or electrical field stimulation was used to study I sc responses. Ca 2ϩ imaging was done in 1,222 neurons responding to high-K ϩ depolarization from 61 surgical cases. The SMP from Roux-en-Y patients is a suitable model to study synaptic transmission in human enteric nervous system (huENS). The P2Y1/G␣q/PLC/inositol 1,3,5-trisphosphate/Ca 2ϩ signaling pathway, N-type Ca 2ϩ channels, nicotinic receptors, and extrinsic nerves contribute to neurotransmission in huENS. Inhibitory AdoA3R inhibit nucleotide or cholinergic transmission in the huENS. purinergic transmission; calcium signaling; adenosine A3 receptors; P2Y 1 receptors; submucous nerve plexus ADENOSINE (ADO) RECEPTORS may offer a novel therapeutic target in gut inflammation, inflammatory bowel disease (IBD) (24) , or other diseases (33, 34, 43, 54) . Ado is a metabolite of ATP that acts at AdoA 1 receptor (AdoA 1 R), AdoA 2a R, AdoA 2b R, or AdoA 3 R on neural and nonneural layers of the gut to influence synaptic transmission, gut reflexes, and function (14, 17, 18) . ATP itself or other nucleotides, like ADP, AMP, UTP, or UTP, act at additional receptors belonging to ionotropic channel P2X1-P2X7 or metabotropic G-protein-coupled P2Y receptors P2Y1, P2Y4, P2Y6, P2Y11-P2Y14 with specific actions in gut neurophysiology (16, 18) .
In general, Ado modulates neural, immune, or sensory signals and may provide cytoprotection or neuroprotection in both the enteric nervous system (ENS) and central nervous system (14, 37, 48, 49) . In the ENS, Ado suppresses synaptic transmission (10) , efferent function of extrinsic capsaicinsensitive sensory nerves (64) , mucosal reflexes (19) , neuroeffector transmission (11) , and morphine withdrawal diarrhea (38) .
Increasing the concentration of endogenous Ado (eAdo) is one mechanism by which several drugs may reduce gut inflammation (1, 2, 6, 28 ). An Ado kinase inhibitor or an AdoA 3 R agonist, N 6 -(3-iodobenzyl)adenosine-5Ј-N-methyluronamide (IB-MECA), may be beneficial in murine models of colitis (42, 56) , but the mechanisms involved remain poorly understood. The sites of action of these drugs and, in particular, whether AdoA 3 Rs are involved remain unclear. AdoA 3 Rs have a wide range of physiological and disease-related effects (18, 21, 34, 41) with promise for treatment of a variety of heart disease, uveitis, colorectal cancer, and inflammation (23, 29, 43, 51) . IB-MECA is in Phase I and II clinical trials for a chronic inflammatory disease, rheumatoid arthritis, and is apparently without toxicity (www.canfite.com/develop.html).
It is increasingly more evident that abnormalities in the ENS, or "little brain of the gut," are involved in IBD or functional bowel diseases (irritable bowel syndrome) that underlie symptoms of constipation, diarrhea, dysmotility, malabsorption and transport, and painful sensations (59) . Purinergic signaling pathways play an important role in sensory signaling in enterochromaffin cells (EC) and secretomotor reflexes in the intestinal tract; purinergic signaling operates at all levels of the EC-neural-secretomotor axis in gut reflexes (16, 18) . Abnormalities in purinergic signaling, such as those that occur in experimental IBD (30) , are expected to influence gut neural reflexes and contribute to symptomology in disease states.
Our recent study (30) assessed the protective effect of an AdoA 3 R agonist, IB-MECA, on gene dysregulation and injury in a rat chronic model of 2,4,6-trinitrobenzene sulfonic acidinduced colitis. Oral IB-MECA prevented abnormal gene expression in 92% of these genes, histopathology, gut injury, and weight loss. IB-MECA or Ado could suppress elevated free radicals in ex vivo inflamed gut. Oral IB-MECA blocked the colitis-induced upregulation of benzodiazepine, P2X 1 receptor (P2X 1 R), P2X 4 R, P2X 7 R, P2Y 2 R, and P2Y 6 R, A 2a R/A 2b R, but not A 1 R or A 3 R genes, or downregulated P2X 2 R, P2Y 1 R, and P2Y 4 R (30).
Neural hypoxia elevates interstitial Ado in networks of enteric ganglia or CA1 hippocampal neurons that suppress transmitter release (26, 47) via AdoA 1 R and possibly AdoA 3 R, based on indirect pharmacological analysis. Such activation of low-affinity AdoA 3 R could protect the ENS by limiting excitability.
The physiological role of AdoA 3 Rs in the brain or ENS has been questioned (13, 21, 50) , because the AdoA 3 R is a lowaffinity receptor that requires high/micromolar concentrations of eAdo for activation: high levels of eAdo occur at sites of inflammation, infection, and metabolic stress (44, 48, 57, 58) . However, in vitro studies demonstrated that ongoing release of eAdo differentially affects excitatory and inhibitory transmission to S or AH neurons in the gut. These effects at high affinity A 1 or non-A 1 /putative A 2 or A 3 receptors (13) serve to complement the ability of Ado to shut down excitatory neural activity in gut microcircuits through its dual pre-and postsynaptic actions (9, 11, 19, 26) .
The AdoA 3 R shows a species-specific distribution (40), pharmacology, function, and diversity of structure (40, 46) . Differential expression of AdoA 3 R mRNAs occurs in the mammalian intestines (13, 27, 40) , and AdoA 3 Rs, as well as AdoA 2a R, AdoA 2b R, and AdoA 1 Rs, are discretely expressed in human myenteric and submucosal neurons (13) . Our laboratory's initial studies also identified an inhibitory limb of the neural motor reflex that may be activated by putative AdoA 3 Rs in rat distal colon (3) . In a guinea pig model of neurogenic diarrhea involving dimaprit/H2 activation of gut reflexes, neural AdoA 3 Rs are involved in inhibitory modulation of a stereotype cyclical pattern of coordinated motility and secretion (5) . In addition, non-A 1 /A 2 inhibitory receptors that may represent putative AdoA 3 Rs gate excitability of enteric AH neurons (14) . Our findings in normal rodent gut, as well as reports by others (25) , suggest a physiological role of low micromolar levels of eAdo at AdoA 3 Rs in intact neural circuits. A functional role for IB-MECA and AdoA 3 Rs is also indicated in synaptic plasticity that represents the likely substrates for learning and memory (21) that may operate in AH/intrinsic primary afferent neurons (IPANs) (18, 32, 65) .
AdoA 3 Rs are, in general, inhibitory receptors in the ENS (F. L. Christofi, unpublished observations; Ref. 16 ). In contrast, the P2Y 1 R is emerging as a significant target for nucleotides in excitatory modulation of EC cell secretion of 5-HT to trigger gut reflexes (8) , excitatory purinergic signaling in mucosal stroking reflexes and synaptic transmission in submucous ganglia (12, 20) , and slow synaptic transmission in submucous plexus (SMP) neurons (67) . P2Y 1 Rs are coupled to G␣q/phospholipase C (PLC)/inositol 1,4,5-trisphosphate (IP 3 )/ Ca 2ϩ signaling in enteric neurons or EC cells (F. L. Christofi, unpublished observations; Refs. 8, 12, 16, 20, 67) .
Purinergic receptor mechanisms involved in the modulation of neuronal excitability or synaptic transmission in the integrated neural circuits of the human ENS (huENS) remain unknown. AdoA 1 R, AdoA 2a R, AdoA 2b R, and AdoA 3 R gene transcripts and proteins are differentially expressed in neural and nonneural layers of the human and rodent intestine, suggesting a role in secretomotor reflexes (13, 18) . We tested the hypothesis that purines modulate synaptic transmission in the huENS by acting at inhibitory AdoA 3 R and excitatory P2Y 1 Rs.
It was necessary to first establish an optical recording technique suitable for monitoring synaptic transmission in the ENS. Fluo 4-acetylmethyl ester (AM) laser confocal Ca 2ϩ imaging was used to record synaptic responses in postsynaptic neurons generated by focal electrical fiber tract stimulation (FTS) of internodal strands, connecting two ganglia in the SMP. Some of the data were presented in preliminary form in two abstracts at the American Gastroenterology Association Meetings (52, 69) .
MATERIALS AND METHODS
Collection of human jejunum specimens. Specimens of human jejunum were collected from obese patients who underwent laparoscopic gastric bypass surgery. The study was approved by the biomedical science institutional review board of The Ohio State University. The human jejunum specimen was immediately given to the investigator by the surgeon within seconds after removal from the patient in the operating room and placed in 4°C oxygenated Krebs solution (in mM: 120 NaCl, 6.0 KCl, 1.2 MgCl 2, 1.35 NaH2PO4, 14.4 NaHCO 3, 2.5 CaCl2, 12.7 glucose). After approval of a pathologist, the specimen was used to carry out biological studies in gut neural layers. The time elapsed from tissue removal from the patient to the laboratory bench was 15 min maximum. The tissue was transferred to a large volume of Krebs (2 liters) at room temperature for 1 h initially, to remove anesthetic medications.
Microdissection and laser scanning confocal microscope fluo-4 AM Ca 2ϩ imaging in human SMP after electrical FTS. The jejunum was opened along the mesenterial border, and nonviable tissue that was damaged by surgical instruments or cauterization was removed after careful macroscopic inspection by an experienced physician scientist. The whole thickness tissue was placed and perfused in oxygenated Krebs at room temperature, pinned and stretched to Sylgard, and carefully microdissected to remove mucosa, circular muscle, and myenteric plexus-longitudinal muscle layers. The dissection took ϳ1 h. The remaining SMP with intact network of ganglia in multiple layers was cut into ϳ1-cm SMP pieces for loading with Ca 2ϩ indicator for separate experiments. We could routinely obtain 8 -12 separate pieces of SMP from one jejunal specimen. Each piece of SMP was loaded with 30 M fluo-4 AM (Molecular Probes, Eugene, OR) for 2 h and then incubated an additional 1 hr in oxygenated Krebs solution at room temperature to cleave the AM from fluo-4 AM. The total time elapse from the tissue removal from the patient to placement of the tissue preparation on the stage of the confocal microscope was ϳ5 h.
Time series analysis of intracellular free calcium at 2-s intervals was done in fluo-4 AM loaded submucous neurons that were monitored by a Zeiss laser scanning confocal microscope (LSM) 410 laser-scanning confocal imaging system through a ϫ40 oil immersion objective (numerical aperture 1.3, working distance ϭ 170 m). LSM Ca 2ϩ imaging was done in single submucous ganglia of the SMP at 2-s intervals (12, 20) . A schematic diagram of the preparation is illustrated in Fig. 1A . Ca 2ϩ imaging was carried out using an Ar-Kr laser to excite the cell at 488 nm, and fluorescence emissions were passed through a FT510 dichroic mirror and collected through a photomultiplier tube equipped with a BP 505-550 filter, positioned in front of the pinhole and light path. Therefore, fluorescence emission is restricted to between 505 and 550 nm. Imaging was done using time series analysis LSM software. Scanned sections had a thickness of 17.5 m. During the experiment, the tissue was perfused with oxygenated Krebs solution at 36 Ϯ 0.5°C with a "solution in-line heater" (Warner Instruments, Hamden, CT) at a perfusion rate of 20 ml/min. An electrode, which was guided by a computerized Eppendorf Micromanipulator 5171, was placed on a fiber tract (or internodal strand connecting 2 ganglia) 0.3 mm away from the recorded ganglion (Fig. 1 ). The number of neurons that responded to FTS could be altered by switching the electrode to another fiber tract, indicative of differences in synaptic inputs from different sites.
After an equilibration period, a 3-s fiber tract electrical stimulus (0.1, 0.5, 1, 5, 10, 25, 50, 75, and 100 Hz) was applied by a 25-m titanium tip (voltage 50 V, duration 0.4 ms). The effects of superfused agonists and antagonists (competitive and noncompetitive) on FTSevoked Ca 2ϩ transients were assessed on FTS before and 20 -30 min after treatment. At the end of each experiment, the recorded ganglion was exposed to 75 mM high-potassium (K ϩ ) solution. Neurons were included in the Ca 2ϩ analysis when they responded to FTS before drug treatment and to high-K ϩ solution at the end of the experiments. Short-circuit current (chloride secretion) recordings. Short-circuit current (I sc ϭ chloride secretion) was recorded in mucosa-submucosa preparations in Ussing flux chambers under voltage clamp. For these experiments, longitudinal muscle with attached myenteric plexus and circular muscle layers were removed from the jejunum specimen. The remaining mucosa-submucosa tissue (M-SMP) was used as a flat sheet, which was pinned down on the inside of an Ussing chamber with a surface area of 1.767 cm 2 . Voltage clamp allowed us to record Isc, which is a measurement of chloride secretion. M-SMP were set up in flux chambers, according to published reports in rodent tissue (39) .
Distension reflexes, electrical field stimulation, and I sc responses. Distension, caused by the removal of 150 l fluid for 30 s from the submucosal compartment, evoked a reflex I sc response. Electrical field stimulation (EFS) with 10 or 20 Hz for 30 s (voltage 15 V, duration 0.5 ms) evoked an I sc in the M-SMP. These frequencies were shown previously to evoke optimal EFS responses that can be used in pharmacological studies. Based on our frequency-response curves to FTS in the Ca 2ϩ studies, a peak response occurred at 10 -20 Hz (see below). Agonists and antagonists drugs were added to the submucosal side after an initial I sc response was evoked by mechanical or electrical stimulation. Synaptic transmission was confirmed by blocking nerve conduction with tetrodotoxin in the end of each experiment.
Colabeling for P2Y 1 and vasoactive intestinal peptide in SMP. Colabeling studies were done for P2Y1R and vasoactive intestinal peptide (VIP) immunoreactivity (ir) in human submucous neurons with polyclonal antibodies. The submucosa was first incubated with P2Y 1R (Alamo, Jerusalem, Israel) and VIP primary antibodies (Peninsula, San Carlos, CA) overnight. FITC and Texas Red-conjugated secondary antibodies were used to show P2Y 1R or VIP-positive neurons. Dual-labeling techniques were applied as previously described (13) .
Statistics. Mean values Ϯ SE were reported. Statistical significance was evaluated by paired or unpaired Student's t-test, depending on the experimental design. The EC 50/IC50 values are obtained from sigmoid cumulative concentration-response curves fitted by a nonlinear curvefitting program (GraphPad Prism 3). For multiple comparisons between different frequencies of FTS, ANOVA followed by post hoc (Dunnett's and Newman-Keuls) tests was used. Some of the pharmacology (i.e., Cl-IBMECA concentration-response curve) was also tested with ANOVA. Statistical analysis was performed using StatView 54.51 (Abacus Concepts, Calabasas, CA). Differences are considered statistically significant for P Ͻ 0.05.
RESULTS
Tissue was obtained from postsurgical specimens in 61 patients undergoing Roux-en-Y gastric bypass surgery (age, 22-65 yr old; body mass index, 35-68 kg/m 2 ). Laser confocal Ca 2ϩ imaging was done in 143 separate experiments in 143 ganglia in different tissues. The n values include all neurons that respond to FTS to the first electrical stimulus without treatment. Responses to agonists or antagonists included all neurons that had an initial FTS response, whether they had small or large effects. This included neurons with a very small response (i.e., even if it was 10%) vs. neurons that had a large response (i.e., 60%).
Each ganglion displayed three to four fiber tracts under the microscope. By stimulation of one fiber tract, a certain number of neurons within the visualized ganglion responded with a synaptic Ca 2ϩ response. Our experimental protocol was restricted to stimulation of a single-fiber tract per recorded ganglion. The ganglia in the human SMP (as is the case in rat SMP) are oriented in all directions; a fiber tract was randomly chosen for stimulation, with no preconception of orientation or direction. Seven hundred and sixty-three neurons (62.44%) out of 1,222 neurons that all responded to high-K ϩ depolarization gave a synaptic Ca 2ϩ response to FTS stimulation. If FTS gave a response in two or more neurons in a ganglion, this was used for full analysis. FTS evoked responses in 2-20 neurons/ganglion.
High-K ϩ depolarization was used at the end of the experiment to confirm the number of neurons in the recorded ganglion that are "viable neurons"; this number was usually greater than that evoked by FTS. The total number of neurons in a ganglion in relation to the number of responsive neurons to high-K ϩ depolarization was not determined in our study. It is likely that only 60% of viable neurons respond to FTS, because we only stimulated one internodal strand. In fact, when we switch the FTS electrode to a different fiber tract, some different neurons are often activated, suggesting that differential recruitment of neurons occurs by stimulating different fiber tracts. The question of recruitment of neurons, convergence and divergence of synaptic responses, deserves further consideration, but was not analyzed further here. To date, Dr. Jan Tack's group has analyzed such responses in guinea pig myenteric neurons using Ca 2ϩ imaging (62 Fig. 1B . The Ca 2ϩ response increased in a frequency-dependent manner from 0.1 to 100 Hz, peaking at 10 -25 Hz and gradually declining by 30 -40% by 100 Hz (Fig. 1C) .
Reproducibility of the Ca 2ϩ response at different frequencies. FTS-Ca 2ϩ responses were evoked repeatedly for 10 consecutive trials at 5-min intervals over a 45-min period at 5, 10, 25, and 35 Hz to assess reproducibility of the response (Fig. 2) . At frequencies of 5, 10, and 35 Hz, ANOVA analysis revealed that the response declined significantly after repeated FTS trials. When stimuli of 25 Hz were applied to fiber tracks, no significant difference was seen during 10 repeated identical stimuli. This frequency was chosen for most pharmacological studies. At 35 Hz, repeated FTS caused a complete inhibition of the elicited Ca 2ϩ response (Fig. 2D ). P2Y 1 R/G␣q/PLC signaling mechanism. To assess the role of the PLC signaling pathway in the FTS Ca 2ϩ response, we sought to investigate the effects of inhibition of PLC using U-73122 or a nucleotide P2Y 1 R-selective antagonist to suppress FTS Ca 2ϩ responses, because P2Y 1 Rs are known to be coupled to a G␣q/PLC/Ca 2ϩ signaling in submucous neurons of the rat and guinea pig intestine and in human ECs (F. L. Christofi, unpublished observations; Refs. 12, 16, 17, 20, 68) .
The selective P2Y 1 R antagonist 2Ј-deoxy-N 6 -methyladenosine 3Ј,5Ј-bisphosphate (MRS-2179; 20 M) or the PLC inhibitor U-73122 (2 M) could block 75-90% of the peak FTS Ca 2ϩ response (Fig. 3, A-C Colocalization of P2Y 1 R-ir in VIP-positive neurons. Colabeling experiments revealed that 39% of VIP-ir neurons in the human SMP displayed strong ir for P2Y 1 R (Fig. 3, D and E ). An additional 30% of neurons were P2Y 1 R ϩ /VIP Ϫ , and 31% of response decreased gradually after 5 stimuli. B: a frequency of 10 Hz also showed a significant decrease of the Ca 2ϩ response (ANOVA, n ϭ 13; P Ͻ 0.05). The Ca 2ϩ responses decreased gradually after the fourth stimulus. C: when stimuli of 25 Hz were applied to fiber tracks, no significant difference was seen during 10 repeated identical stimuli (ANOVA, n ϭ 6; P ϭ 0.25). D: FTS at 35 Hz was the least reproducible after the fourth consecutive stimulus, and responses could no longer occur from the seventh to the tenth stimulus (ANOVA, n ϭ 6; P Ͻ 0.01). ⌬, Change. , or blockade of N-VOCC using ⍀-conotoxin MVIIA (Fig. 4) . In control experiments, repeated FTS Ca 2ϩ responses at 0, 5, 25, and 30 min caused only a very modest reduction in peak Ca 2ϩ response (Ͻ10%, Fig. 4A ). Hexamethonium caused a 50% reduction in the FTS Ca 2ϩ response (Fig. 4B) , and ⍀-conotoxin blocked 70 -80% of the response. High-Mg 2ϩ /low-Ca 2ϩ perfusion caused an 80% suppression of the response that was reversible with washout ( Fig. 4D) .
Blockade of the extrinsic and intrinsic pathways with capsaicin and TTX. Capsaicin (10 M) inhibited the FTS-evoked Ca 2ϩ response by ϳ25% in submucous neurons of the intact SMP (Fig. 5A) . Blockade of nerve conduction with TTX could abolish FTS-evoked Ca 2ϩ responses (Fig. 5B) . The distension-evoked I sc response was reduced 29% by 10 M capsaicin alone. Capsaicin, together with 1 M TTX, reduced the I sc response by 64% (Fig. 5C) .
MRS-1220 augments synaptic and distension-evoked responses in human intestine. The human AdoA 3 R-selective antagonist MRS-1220 alone at 1 or 10 M concentrations could augment the FTS-Ca 2ϩ response (Fig. 6A) . The rodent- (4, 5) . FTS was at 25 Hz for 3 s. In the end of the experiment, the ganglion was exposed to a 75 mM K ϩ Krebs solution (6) 
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selective AdoA 3 R antagonist MRS-1191 had no effect on synaptic Ca 2ϩ responses; the synaptic Ca 2ϩ response was not augmented by 1 M MRS-1191 (38.2 Ϯ 2.6 to 41.7 Ϯ 4.1 pixels, P ϭ 0.06; 8 neurons) or 10 M MRS-1191 (44.9 Ϯ 3.1 to 49.7 Ϯ 2.4 pixels, P ϭ 0.081; 43 neurons). MRS-1220 also enhanced the distension-evoked I sc response by 31%, and enhancement was blocked and slightly further reduced by 1 M TTX (Fig. 7B) .
Inhibition of synaptic Ca 2ϩ responses by activation of AdoA 3 Rs. The selective AdoA 3 R agonist 2-chloro-N 6 -(3-iodobenzyl)adenosine-5'-N-methyl-carboxamide (2-Cl-IBMECA) (5 M) could abolish the FTS-Ca 2ϩ response at frequencies ranging from 0.5 to 25 Hz. At higher frequencies, 2-Cl-IBMECA was less effective, but significantly inhibited the FTS-Ca 2ϩ response (Fig. 7A ). 2-Cl-IBMECA caused a concentration-dependent inhibition of the 25-Hz FTS-evoked Ca 2ϩ response. At a concentration of 5 M 2-Cl-IBMECA, the Ca 2ϩ response was nearly abolished. The apparent IC 50 for 2-Cl-IBMECA inhibition of the FTSevoked Ca 2ϩ response is ϳ8.5 ϫ 10 Ϫ8 M (Fig. 7B ). The human AdoA 3 R selective antagonist MRS-1220 augmented the frequency-Ca 2ϩ response at 1-35 Hz in human submucous neurons in response to FTS. The effect of MRS-1220 was greatest at 25 and 35 Hz. In contrast, in control experiments, vehicle instead of MRS-1220 did not augment the FTS-Ca 2ϩ response (Fig. 7, C and D) . In the presence of 5 M 2-Cl-IBMECA, MRS-1220 could no longer augment the FTSCa 2ϩ response (Fig. 7E) . It is possible that AdoA 1 Rs contribute to the inhibitory effect of the AdoA 3 R agonist 2-Cl-IBMECA, and, therefore, we carried out additional experiments in the presence of the irreversible AdoA 1 R antagonist 8-cyclopentyl-3-N-(3-{[3-(4-fluorosulphonyl)benzoyl]-oxy}-propyl)-1-N-propyl-xanthine (FSCPX) to knock down AdoA 1 R. FSCPX alone did not augment the FTS-Ca 2ϩ response in submucous neurons (Fig.  7F) . At a concentration of 1 M FSCPX, which is sufficient to block all high-affinity AdoA 1 Rs (60), the AdoA 3 R agonist 2-Cl-IBMECA could still suppress the FTS-evoked Ca 2ϩ response at frequencies ranging from 1 to 35 Hz (Fig. 7G) .
EFS does not reveal an AdoA 3 R. EFS at 10 or 20 Hz was used to elicit a TTX-sensitive Cl Ϫ secretory response in M-SMP. Knockdown of AdoA 1 Rs with FSCPX caused a modest but significant augmentation of the 20-Hz EFS-induced I sc response in M-SMP; no effect was observed at 10 Hz. After knockdown, 2-Cl-IBMECA had no effect on the 10-or 20-Hz EFS-induced I sc response in M-SMP (Fig. 8) .
DISCUSSION
To our knowledge, this is the first study to provide proof that purinergic modulation of synaptic transmission occurs in the human SMP, which may be important in mucosal reflexes and distension reflexes (F. L. Christofi connective leads to a synaptic Ca 2ϩ response in 64% of viable neurons in recorded ganglia; this implies that a majority of neurons within each ganglion receive significant synaptic inputs. The FTS response recorded in jejunum ganglia obtained from 61 different Roux-en-Y surgery cases involves neuronal conduction and synaptic transmission because it is sensitive to TTX, high-Mg 2ϩ /low-Ca 2ϩ solutions, -conotoxin, and hexamethonium and displays inhibition to high-frequency stimulation. Previous work using calcium indicators revealed activitydependent changes in intracellular calcium levels in response to electrical stimulation in both AH and S electrophysiological types of enteric neurons (4, 31, 35, 36, 55, 62) . The FTS frequencies used in the present study are known to generate multiple action potentials associated with a transient elevation in Ca 2ϩ levels. A high frequency or train stimulus (this study) would elicit a slow excitatory postsynaptic potential (EPSP) response with superimposed action potentials; the hexamethonium response observed would further imply that multiple fast nicotinic EPSPs contribute to the overall EPSP response. These fast EPSP responses are more easily recorded and distinguished by multisite optical recording techniques with a voltage-sensitive dye (53) . Synaptic Ca 2ϩ responses in the huENS are repeatable, reproducible, and quantifiable.
Synaptic transmission in human submucous ganglia. Our study provides proof for nerve conduction (TTX sensitivity), neurotransmission (high Mg 2ϩ /low Ca 2ϩ , and -conotoxin sensitivity), the types of neurotransmitters involved in neurotransmission (nucleotides, ACh), as well as the signaling pathways and receptors involved in synaptic transmission in the intact neural circuits of human submucous ganglia. HighMg 2ϩ /low-Ca 2ϩ solutions remove Ca 2ϩ involved in neuro- 
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transmission, or they would be acting to induce Ca 2ϩ -induced Ca 2ϩ release from intracellular ryanodine-sensitive or IP 3 -sensitive stores. N-type Ca 2ϩ channels that are sensitive to -conotoxin are involved in the synaptic Ca 2ϩ response in human submucous neurons. At presynaptic sites, N-type Ca 2ϩ channels may play an important role in transmitter release (36, 63, 66) . Therefore, the Ca 2ϩ response is synaptically driven, since it is sensitive to -conotoxin. In guinea pig myenteric plexus, synaptic Ca 2ϩ transients were sensitive to the same manipulations of TTX, -conotoxin, and high Mg 2ϩ /low Ca 2ϩ (4) . N-type Ca 2ϩ channels could also be operating in the cell somas or enteric neurons. Action-potential-dependent Ca 2ϩ transients in the cell somas of enteric S neurons were shown to be blocked by ϳ70% by -conotoxin (55), and it has been suggested that -conotoxin-resistant Ca 2ϩ responses may represent antidromic activation of neurons, such as could occur with FTS.
Species differences in synaptic Ca 2ϩ signals between human and rat SMP. In an earlier preliminary study, we characterized synaptic Ca 2ϩ signaling pathways to electrical FTS in a rat preparation of SMP that is similar to human, at least anatomically, with several layers of submucous ganglia as in human (7). It is noteworthy that synaptic Ca 2ϩ signaling mechanisms in the rat SMP differ significantly than those in the human SMP, stressing the importance of carrying out a study in human SMP, albeit a much more complex preparation. In rat SMP, unlike the human SMP, the synaptic Ca 2ϩ response is mediated primarily by a cAMP-dependent mechanism and is blocked by a protein kinase A inhibitor. In human SMP (this study), the P2Y 1 /G␣q/PLC/IP 3 /Ca 2ϩ signaling pathway predominates. In rat SMP, MRS-2179 could only block synaptic Ca 2ϩ responses in 23% of neurons. Also different, nicotinic cholinergic transmission plays a minor role in synaptic Ca 2ϩ responses in rat SMP. Such differences deserve further study in human SMP.
Role of inhibitory AdoA 3 R and excitatory P2Y 1 Rs in synaptic transmission. All previous work on purinergic regulation in the gut and gut reflexes was done in rodents (16, 18) . The physiological role of AdoA 3 Rs in the brain or ENS has been questioned (13, 21, 50) because the AdoA 3 R is a low-affinity receptor that requires high/micromolar concentrations of eAdo for activation; high levels of eAdo occur at sites of inflammation, infection, and metabolic stress (22, 44, 48, 57, 58) . Earlier studies showed that ongoing release of eAdo in micromolar 
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levels differentially affects excitatory and inhibitory transmission in the gut. These effects at high affinity A 1 or non-A 1 /putative A 2 or A 3 Rs (13) serve to complement the ability of Ado to shut down excitatory neural activity in gut microcircuits through its dual pre-and postsynaptic actions (9, 11, 19, 26) .
In this study, activation of the AdoA 3 R inhibits synaptic transmission in the human SMP. Several lines of evidence support the hypothesis that AdoA 3 Rs are negatively coupled to synaptic transmission in the huENS. First of all, it is known that AdoA 3 R-ir is discretely localized in human submucous neurons (13) . The IC 50 concentration of the potent and selective AdoA 3 R agonist 2-Cl-IBMECA in suppressing the synaptic Ca 2ϩ response was 8.5 ϫ 10 Ϫ8 M. To rule out the possibility that 2-Cl-IBMECA is acting at high-affinity AdoA 1 R (known to exist in submucous neurons) instead of AdoA 3 Rs, the irreversible AdoA 1 R antagonist FSCPX that forms a covalent bond with its receptor (60) was used to knock down AdoA 1 R. The ability of 2-Cl-IBMECA to suppress or abolish the synaptic Ca 2ϩ response after knockdown and the antagonistic effect of the selective AdoA 3 R antagonist MRS-1220 strongly argue for an AdoA 3 R, not AdoA 1 R, in the 2-Cl-IBMECA effect. The potency of 2-Cl-IBMECA in human submucous neurons was 10-fold greater than that reported for guinea pig colonic enteric neurons (IC 50 ϭ 0.8 M) in a model of secretory diarrhea, in which 2-Cl-IBMECA was able to suppress the dimaprit/H2-evoked cyclical coordinated pattern of motility and secretion (5) . AdoA 3 R shows a speciesspecific distribution (40) , pharmacology, and diversity of structure (41) that could explain the difference in potency of the AdoA 3 R agonist between human (this study) and guinea pig (5) submucous neurons. Other studies also identified an inhibitory limb of the neural motor reflex that may be activated by putative AdoA 3 Rs in rat distal colon, further arguing for a physiological role of AdoA 3 R in the ENS (3). In addition, non-A 1 /A 2 inhibitory receptors that may represent putative AdoA 3 Rs gate excitability of enteric AH neurons (14) . Our findings in normal rodent gut, as well as reports by others (25) , suggest a physiological role of low micromolar levels of eAdo at AdoA 3 Rs in intact neural circuits. A functional role for IB-MECA and AdoA 3 Rs is also indicated in synaptic plasticity that represent the likely substrates for learning and memory (21) that may operate in AH/IPANs (18, 32, 65) . AdoA 3 Rs are negatively coupled to nucleotide and cholinergic synaptic transmission. 2-Cl-IBMECA was most effective at lower frequencies of FTS, and, in the range of 0.5-to 25-Hz frequencies, activation of AdoA 3 R could abolish synaptic transmission. At higher frequencies, it could only partially inhibit synaptic transmission, indicating an AdoA 3 R-resistant component to synaptic transmission. We did not do an exhaustive analysis of the putative transmitters released at each of the frequencies that could be inhibited by AdoA 3 Rs. However, at 25-Hz frequency, we can conclude that nucleotides (ATP or ADP) are a major contributor to the FTS synaptic Ca 2ϩ response, since it could be blocked by a P2Y 1 R antagonist. Nicotinic cholinergic transmission is involved in ϳ50% of responsive neurons that were sensitive to hexamethonium blockade of synaptic Ca 2ϩ responses. Since 2-Cl-IBMECA could abolish the 25-Hz FTS response, it would follow that activation of AdoA 3 Rs leads to suppression of purinergic and cholinergic transmission in the human SMP. At higher frequencies, 35-100 Hz, the identity of the transmitter(s) that is not sensitive to 2-Cl-IBMECA inhibition remains unknown. Also, we could not delineate whether effects of 2-Cl-IBMECA were at pre-and/or postsynaptic AdoA 3 Rs. Both sites are possible, since AdoA 3 R-ir has been identified on substance P varicose fibers and cell somas of SP or VIP neurons in rat and human intestine ( Our study provides strong pharmacological evidence for activation of AdoA 3 R in intact neural circuits of the human SMP by eAdo; the AdoA 3 R antagonist MRS-1220 alone that prefers the human AdoA 3 R (but not a rodent selective antagonist MRS-1191) was effective in revealing an inhibitory influence of eAdo at AdoA 3 R on synaptic transmission in human submucous ganglia. Collectively, this study in human submucous ganglia, our laboratory's preliminary data in normal rodent gut (8) , as well as reports by others (25) , suggest a physiological role of low-micromolar levels of eAdo at AdoA 3 Rs in intact neural circuits. A functional role for IB-MECA and AdoA 3 Rs is also suggested in synaptic plasticity that represents the likely substrates for learning and memory (29) that may operate in AH/IPANs (18, 32, 65) . However, it is also very likely that these receptors are important in abnormal or disease states of the gut, given that low-affinity AdoA 3 Rs can be more fully activated by high levels of Ado that can be released during disease and inflammation (22, 44, 48, 57, 58) . AdoA 3 Rs are subject to dysregulation in a profilin transgenic mouse with gut smooth muscle hypertrophy (F. L. Christofi and H. H. Hassanain, unpublished observations), a rabbit Crohn's/ileitis model (61), gut tissue placed in organotypic culture (F. L. Christofi, unpublished observations; Ref. 16) , and 2,4,6-trinitrobenzene sulfonic acid colitis (30) , and A 3 R overexpression could be useful as a genetic therapy (13) . Nerve terminals, neutrophils, and endothelial cells are known to release high levels of eAdo at sites of inflammation, infection, and metabolic stress that can activate the low-affinity AdoA 3 R. Studies are underway to assess whether gut neural AdoA 3 Rs behave differently in IBD (ulcerative colitis and Crohn's disease).
Transgenic manipulation of A 3 Rs provides a unique opportunity to study A 3 R signaling and proof of physiological effect of A 3 R agonists in gut reflexes (or protective effect in experimental colitis). Our current focus is on the use of transgenic A 3 R knockout and profilin mouse models for the study of the physiological functions of the A 3 R, including secretomotor function and synaptic transmission in intact neural circuits of the SMP, as well as the consequences of A 3 R inhibition on animal models of inflammatory bowel disease (45) .
The P2Y 1 16 ). In contrast, the P2Y 1 R is emerging as a significant target for nucleotides in excitatory modulation of EC cell secretion of 5-HT to trigger gut reflexes (8) , excitatory purinergic signaling in mucosal stroking reflexes and synaptic transmission in submucous ganglia of the rodent intestine (12, 20) , and slow synaptic transmission in SMP neurons (67) . P2Y 1 Rs are coupled to G␣q/PLC/IP 3 /Ca 2ϩ signaling in enteric neurons or EC cells (Refs. 8, 12, 16, 18, 20, 67) .
In this study, we provide pharmacological evidence to support the hypothesis that P2Y 1 /G␣q/PLC/Ca 2ϩ signaling is a predominant pathway involved in synaptic transmission in intact neural circuits of the human submucous nerve plexus. A P2Y 1 -selective antagonist MRS-2179 prevents synaptic Ca 2ϩ signaling in submucous ganglia, indicating that nucleotide release (ATP or ADP) during FTS activates postsynaptic excitatory P2Y 1 R on the postsynaptic membrane of neurons to elevate intracellular free Ca 2ϩ levels. The selective PLC inhibitor is effective in blocking Ն80% of the synaptic Ca 2ϩ response. Furthermore, recent evidence from detailed pharmacological and molecular signaling studies supports the hypothesis that modulation of 5-HT release from human ECs occurs via excitatory P2Y 1 R coupled to the G␣q/PLC/IP 3 /Ca 2ϩ signaling pathway, leading to 5-HT release (68, 70) . In parallel to this mechanism, during FTS in human submucous ganglia, calcium influx in neurons during synaptic activation and action potential generation involve -conotoxin-sensitive N-type Ca 2ϩ channels. Our study provided pharmacological evidence for purinergic excitatory transmission via P2Y 1 Rs. P2Y 1 R-ir is expressed on 39% of submucous neurons with VIP, and another subpopulation of neurons expresses P2Y 1 R but not VIP-ir (30% of neurons); the identity of these neurons remains unknown. In our laboratory's previous study, it was shown that Ͻ10% of VIP neurons in the human SMP expressed AdoA 3 R-ir, whereas most substance P immunoreactive neurons expressed AdoA 3 R-ir (13) . Therefore, it is likely that separate populations of submucous neurons exist with P2Y 1 R and AdoA 3 R, although colocalization studies would be necessary to provide direct proof. This was not technically feasible with the antisera available to us.
Mechanical or chemical activation of the mucosa can lead to an intestinal neural reflex and an increase in ion transport and fluid secretion. To date, only a few studies in rodents have investigated purinergic P2Y 1 R regulation of secretomotor function (12, 17, 19, 20) . Mucosal distortion by brush stroking or distension can elicit the reflex. P2Y 1 -ir was identified in a majority of VIP, nitric oxide synthase, calretinin, neuropeptide Y, or somatostatin neurons, but not SP or calbindin submucous neurons (12) . Mucosal touch/distension-evoked fluo 4/Ca responses in submucous neurons were also inhibited by apyrase or blocked completely by MRS-2179; MRS-2179 only reduced I sc in stroking reflexes. It was concluded from those studies that several nucleotides may contribute to mechanically evoked secretomotor reflexes, including P2Y 1 Rs. It is likely that purinergic (P2Y 1 R) transmission in human gut is also involved in secretomotor reflexes, but this awaits proof.
Distension reflexes, EFS, and intrinsic/extrinsic nerves in the AdoA 3 R responses. In the M-SMP preparation, distensionevoked mucosal secretion (i.e., I sc /chloride secretion) involves both intrinsic (TTX-sensitive) and extrinsic (capsaicin-sensitive) nerve fibers. Distension-evoked secretion is augmented by the human selective AdoA 3 R antagonist MRS-1220, lending support to the concept that distension releases sufficient Ado or a related nucleotide precursor (i.e., AMP, ADP, ATP) that breaks down to Ado to activate a low-affinity AdoA 3 R. Extrinsic nerves with sensitivity to capsaicin are minor contributors to the synaptic Ca 2ϩ response in submucous neurons; these are presumed to be nerve fibers that remain intact in the ganglia after acute microdissection of the M-SMP from human jejunum. The effect of MRS-1220 is blocked completely by TTX, indicating that the AdoA 3 R mechanism is restricted to intrinsic nerves in the human SMP.
Interestingly, when EFS stimulation was used to evoke a neural I sc /chloride secretory response, no AdoA 3 R could be revealed by using an AdoA 3 R-selective agonist 2-Cl-IB-MECA. EFS activates all neurons in the neural circuits of the SMP indiscriminately and in both the ortho-and antidromic directions, making it more difficult to reveal an inhibitory AdoA 3 R component at 10-or 20-Hz stimulation frequency. EFS did reveal an AdoA 1 R inhibitory component at 20 Hz with the AdoA 1 R antagonist FSCPX, suggestive of sufficient eAdo release to activate this high-affinity receptor. In contrast, FTS could not reveal an AdoA 1 R component. However, FTS stimulation of an internodal strand activates a more discrete synaptic pathway and can reveal a prominent AdoA 3 R component to synaptic transmission. In the intact mucosa-submucosa, AdoA 3 Rs are located on both ECs (sites of 5-HT release to trigger gut mucosal reflexes) and submucous neurons. In human EC cells, eAdo is sufficient to provide ongoing inhibition of basal and mechanically evoked 5-HT release via AdoA 3 Rs (8) . Another possibility to explain the lack of A 1 R functional responses in synaptic transmission is the potential downregulation or internalization of the receptor during the postsurgical period and processing of the tissue: from tissue removal in the operating room to Ca 2ϩ imaging, it takes ϳ5 h, and, during this time, the A 1 R could undergo changes in expression. Furthermore, it is know that the A 1 becomes internalized after activation, and it takes up to 24 h for trafficking back to the membrane. In fact, we found that, in human EC cells, we could reveal an A 1 inhibition response only after protection of the A 1 R from activation and internalization by eAdo by blocking it with an A 1 antagonist overnight (8) .
Conclusions. Collectively, data in human EC cells and the intact neural circuits of the human SMP (this study) support the unified hypothesis that inhibitory AdoA 3 Rs and excitatory P2Y 1 Rs modulate mucosal reflexes by acting at receptors in the EC-neural secretomotor reflex arc (8, 16, 18) . In this study, 2-Cl-IBMECA or eAdo can activate AdoA 3 Rs to suppress distension reflexes, as well as synaptic cholinergic and purinergic transmission in the human SMP. Nucleotides released during electrical stimulation of internodal strands release neurotransmitters that activate a major excitatory P2Y 1 /G␣q/PLC/ IP 3 /Ca 2ϩ signaling pathway and N-type Ca 2ϩ channels in the postsynaptic neurons; these mechanisms are important for communication between neurons in the "little brain" of the human gut.
